Phosphodiesterase Type-5 Inhibitors and Glaucoma

International Ophthalmology Clinics · Published 2026-06-18 · DOI 10.1097/iio.0000000000000630

Authors (2)

Abdelrahman M. Elhusseiny, Swarup S. Swaminathan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Elhusseiny, A., Swaminathan, S. (2026). Phosphodiesterase Type-5 Inhibitors and Glaucoma. International Ophthalmology Clinics. https://doi.org/10.1097/iio.0000000000000630

Related articles

• Strabismus Surgery in Thyroid Eye Disease · International Ophthalmology Clinics · 2026 · Same journal
• Ocular and Periocular Squamous Cell Carcinoma · International Ophthalmology Clinics · 2025 · Same journal
• Home Tonometry and Perimetry: Addressing an Unmet Need in Glaucoma Care · International Ophthalmology Clinics · 2026 · Same journal
• Gene Therapy in Age-related Macular Degeneration · International Ophthalmology Clinics · 2025 · Same journal
• Pediatric Cranial Nerve Palsies · International Ophthalmology Clinics · 2026 · Same journal
• Eyeing Opportunity: A Review of Private Equity in Ophthalmology · International Ophthalmology Clinics · 2025 · Same journal
• Paraneoplastic Syndromes in the Orbit and Ocular Adnexa: A Comprehensive Review · International Ophthalmology Clinics · 2025 · Same journal
• Beyond the Bottle: Lessons From the Laser in Glaucoma and Ocular Hypertension Trial · International Ophthalmology Clinics · 2026 · Same journal
• Applications of New Generation Sequencing (NGS) in Ocular Oncology · International Ophthalmology Clinics · 2025 · Same journal
• Nonorganic Ophthalmic Conditions in Children · International Ophthalmology Clinics · 2026 · Same journal